New plant variety protection in China

New plant varieties are protected nowhere better than they are in China; today, the country has the largest number of annual applications for agricultural plant variety rights. Mengmeng Yu explains the rules and procedures a plant breeder must know to protect rights for new plant varieties in China.

Read On

__________________________________________________________________________________________________________

The latest developments in patent validity examination in China

As China’s patent system has improved dramatically in recent years, patent holders are expected to become significantly more willing to choose China as their venue for litigation. Shengxiang Fan explains how the system has been improved, and what that means for owners of patent rights.

Read On

__________________________________________________________________________________________________________

Developing a trademark enforcement strategy guided by Sun Tzu and Carl von Clausewitz

There is no “one size for all” strategy for trademark enforcement actions, but Aimin Huo argues that brand owners should make themselves invincible – and then await the enemy’s moment of vulnerability, something like Sun Tzu suggested centuries ago.

Read On

__________________________________________________________________________________________________________

It’s time to update your patent protection strategies in China

Administrative adjudication is taking on a larger role in Chinese patent protection strategies. Frank Chen explains why administrative adjudication should be a preferred way to resolve patent infringement disputes, especially when the infringer is located in a developed province.

Read On

__________________________________________________________________________________________________________

China’s pharma industry prepares for its own patent linkage system

China is about to witness the birth of its own patent linkage system. Jonathan Miao describes the system of “Chinese character,” and the significant impacts it will have on China’s pharmaceutical industry, particularly branded companies and drug innovators.

Read On